यूरोपीय संघ - फ़िनिश - EMA (European Medicines Agency)

accord healthcare s.l.u. - fampridine - multippeliskleroosi - muut hermoston huumeet - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

यूरोपीय संघ - फ़िनिश - EMA (European Medicines Agency)

accord healthcare s.l.u. - kabatsitakseli - eturauhasen kasvaimet, kastraatio-resistentin - antineoplastiset aineet - treatment of patients with hormone refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen.

यूरोपीय संघ - फ़िनिश - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriflunomidi - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit, selektiiviset immunosuppressantit - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

फ़िनलैंड - फ़िनिश - Fimea (Suomen lääkevirasto)

accord healthcare b.v. - mitomycin - injektio/infuusiokuiva-aine, liuosta varten - 20 mg - mitomysiini

फ़िनलैंड - फ़िनिश - Fimea (Suomen lääkevirasto)

accord healthcare b.v. - carbidopa, entacapone, levodopa - tabletti, kalvopäällysteinen - 100 mg / 25 mg / 200 mg - levodopa

फ़िनलैंड - फ़िनिश - Fimea (Suomen lääkevirasto)

accord healthcare b.v. - carbidopa, entacapone, levodopa - tabletti, kalvopäällysteinen - 150 mg / 37,5 mg / 200 mg - levodopa

फ़िनलैंड - फ़िनिश - Fimea (Suomen lääkevirasto)

accord healthcare b.v. - carbidopa, entacapone, levodopa - tabletti, kalvopäällysteinen - 200 mg / 50 mg / 200 mg - levodopa

यूरोपीय संघ - फ़िनिश - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, tyyppi 2 - diabeetilla käytettävät lääkkeet - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 käytettävissä olevista tiedoista eri yhdistelmistä).

फ़िनलैंड - फ़िनिश - Fimea (Suomen lääkevirasto)

accord healthcare b.v. - carbidopa, entacapone, levodopa - tabletti, kalvopäällysteinen - 50 mg / 12,5 mg / 200 mg - levodopa

फ़िनलैंड - फ़िनिश - Fimea (Suomen lääkevirasto)

accord healthcare b.v. - carbidopa, levodopa, entacapone - tabletti, kalvopäällysteinen - 75 mg / 18,75 mg / 200 mg - levodopa